Related references
Note: Only part of the references are listed.Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
Bastien Nguyen et al.
CELL (2022)
The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
Monica Fedele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma
Xiaoying Fan et al.
CELL DISCOVERY (2022)
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
Qing Li et al.
CANCER DISCOVERY (2022)
How a cell decides its own fate: a single-cell view of molecular mechanisms and dynamics of cell-type specification
Maria Mircea et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2021)
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer
Komal Jhaveri et al.
CLINICAL CANCER RESEARCH (2021)
Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial-Mesenchymal Plasticity
Barbora Kvokackova et al.
CANCERS (2021)
Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies
Yajie Wang et al.
BRITISH JOURNAL OF CANCER (2021)
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
Philippe Aftimos et al.
CANCER DISCOVERY (2021)
HUNK phosphorylates EGFR to regulate breast cancer metastasis
Carly B. Williams et al.
ONCOGENE (2020)
Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells
Xingru Li et al.
CANCERS (2020)
Current concepts in tumour-derived organoids
Ross J. Porter et al.
BRITISH JOURNAL OF CANCER (2020)
Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression
Soulafa Mamlouk et al.
BMC BIOLOGY (2020)
Modeling tumor development and metastasis using paired organoids derived from patients with colorectal cancer liver metastases
He Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis
Hye-Young Nam et al.
MOLECULAR CANCER RESEARCH (2019)
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Nishant Gandhi et al.
CELLS (2019)
Genomic characterization of metastatic breast cancers
Francois Bertucci et al.
NATURE (2019)
Cancer modeling meets human organoid technology
David Tuveson et al.
SCIENCE (2019)
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
Lindsay Angus et al.
NATURE GENETICS (2019)
Multi-Omics Characterization of the Spontaneous Mesenchymal-Epithelial Transition in the PMC42 Breast Cancer Cell Lines
Sugandha Bhatia et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias et al.
EUROPEAN JOURNAL OF CANCER (2019)
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
Eylem Kulkoyluoglu-Cotul et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER CELL (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models
Garima Kaushik et al.
STEM CELLS (2018)
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
John Marquart et al.
JAMA ONCOLOGY (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists
Weiyi Toy et al.
CANCER DISCOVERY (2017)
Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
Qi Wu et al.
ONCOTARGET (2017)
Metabolic advantages and vulnerabilities in brain metastases
Alexandra K. Ciminera et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Genomic Evolution of Breast Cancer Metastasis and Relapse
Lucy R. Yates et al.
CANCER CELL (2017)
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
Kara N. Maxwell et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
Masayuki Fujii et al.
CELL STEM CELL (2016)
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
Celine Lefebvre et al.
PLOS MEDICINE (2016)
Biologic subtype is a more important prognostic factor than nodal involvement in patients with stages I and II breast carcinoma
Hyosun Kim et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2016)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy et al.
CELL METABOLISM (2015)
Metabolic Plasticity of Metastatic Breast Cancer Cells: Adaptation to Changes in the Microenvironment
Rui V. Simoes et al.
NEOPLASIA (2015)
Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain
Jinyu Chen et al.
CANCER RESEARCH (2015)
Human breast cancer metastases to the brain display GABAergic properties in the neural niche
Josh Neman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
Helene Pelicano et al.
BREAST CANCER RESEARCH (2014)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Suzanne A. Eccles et al.
BREAST CANCER RESEARCH (2013)
Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
G. Frisk et al.
BRITISH JOURNAL OF CANCER (2012)
Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
Oscar H. Ocana et al.
CANCER CELL (2012)
Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer
Sarat Chandarlapaty et al.
CLINICAL CANCER RESEARCH (2012)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Signaling pathways in breast cancer metastasis - novel insights from functional genomics
Mario Andres Blanco et al.
BREAST CANCER RESEARCH (2011)
Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
Y. Kataoka et al.
ANNALS OF ONCOLOGY (2010)
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis
Elise M. Pelletier et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Adaptation of energy metabolism in breast cancer brain metastases
Emily I. Chen et al.
CANCER RESEARCH (2007)
Share Paper
